Guillain-Barré syndrome (GBS)

Guillain-Barré syndrome (GBS)

What is Guillain-Barré syndrome (GBS)?
Guillain-Barré syndrome GBS is a very rare but potentially severe neurological adverse event that is associated with the administration of various vaccines ...
What are the symptoms of Guillain-Barré syndrome (GBS)
Symptoms of GBS range from mild to severe, and may include muscle weakness, muscle pain, numbness, and tingling. In many cases, GBS resolves with no serious...
Guillain-Barré syndrome (GBS) and COVID-19 Vaccine Janssen.
As of 12 September 2022, SAHPRA has been informed of a second fatal case of Guillain-Barré syndrome (GBS) following vaccination with the COVID-19 Vaccine Ja...
How did SAHPRA discover the Covid-19 vaccine deaths?
The South African health product regulatory authority (SAHPRA) has been doing ongoing surveillance of the vaccine rollout since it began and tries to invest...
Is GBS treatable?
GBS is treatable in hospital. There are therapies which includes immunoglobulin therapy (this works on the immune system.) Most people recover but the time ...
When was the first GBS linked death?
On the 04th of August 2022, SAHPRA issued a media statement relating to the first fatal case of Guillain-Barré syndrome (GBS) following vaccination with COV...
Who is at risk of getting GBS?
GBS is rare. It generally affects 1-2 people per 100 000. Anyone can develop it regardless of vaccination status and there is no way of knowing who may be a...
Are there any GBS deaths linked to Pfizer vaccination in SA?
There have been reports of GBS following the Pfizer Covid vaccination in other countries, which were extremely rare.